Vasoactive intestinal polypeptide as mediator of asthma

Groneberg, David A., Springer, Jochen and Fischer, Axel (2001) Vasoactive intestinal polypeptide as mediator of asthma. Pulmonary Pharmacology & Therapeutics, 14 (5). pp. 391-401. ISSN 1522-9629

Full text not available from this repository.


Vasoactive intestinal polypeptide (VIP) is one of the most abundant, biologically active peptides found in the human lung. VIP is a likely neurotransmitter or neuromodulator of the inhibitory non-adrenergic non-cholinergic airway nervous system and influences many aspects of pulmonary biology. In human airways VIP-immunoreactive nerve fibres are present in the tracheobronchial airway smooth muscle layer, the walls of pulmonary and bronchial vessels and around submucosal glands. Next to its prominent bronchodilatory effects, VIP potently relaxes pulmonary vessels. The precise role of VIP in the pathogenesis of asthma is still uncertain. Although a therapy using the strong bronchodilatory effects of VIP would offer potential benefits, the rapid inactivation of the peptide by airway peptidases has prevented effective VIP-based drugs so far and non-peptide VIP-agonists did not reach clinical use.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology
Depositing User: Rhiannon Harvey
Date Deposited: 09 Jun 2011 15:32
Last Modified: 27 Oct 2023 00:44
DOI: 10.1006/pupt.2001.0306

Actions (login required)

View Item View Item